Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
103
Frequently Asked Questions
What is Market Cap of Seres Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Seres Therapeutics Inc market cap is $169.49M.
What is the 52-week high for Seres Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Seres Therapeutics Inc 52 week high is $24.20 as of September 09, 2025.
What is the 52-week low for Seres Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Seres Therapeutics Inc 52 week low is $6.53 as of September 09, 2025.
What is Seres Therapeutics Inc stock price today?
Seres Therapeutics Inc stock price today is $22.85.
What was Seres Therapeutics Inc stock price yesterday?
Seres Therapeutics Inc stock price yesterday was $19.36.
What is the PE ratio of Seres Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Seres Therapeutics Inc’s P/E ratio is -2.44.
What is the Price-to-Book ratio of Seres Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Seres Therapeutics Inc P/B ratio is 5.1438.
What is the 50-day moving average of Seres Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Seres Therapeutics Inc 50-day moving average is $14.86.
How many employess does Seres Therapeutics Inc has?